Filing Details
- Accession Number:
- 0001209191-19-061667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-20 21:00:50
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2019-12-20 21:00:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1510487 | Principia Biopharma Inc. | PRNB | Pharmaceutical Preparations (2834) | 263487603 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1768239 | Dolca Thomas | C/O Principia Biopharma Inc. 220 E. Grand Avenue South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-19 | 495 | $60.00 | 494 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 493 shares and 496 shares acquired under the Employment Stock Purchase Plan on May 15, 2019 and November 15, 2019 respectively.
Billionaire Hedge Funds
